Carswell, Christopher I.; Perry, Caroline M.; Ibbotson, Tim - In: Disease Management and Health Outcomes 11 (2003) 11, pp. 745-765
methotrexate. In addition, leflunomide has been shown to be a cost effective option compared with etanercept, infliximab and … infliximab plus methotrexate. Leflunomide was generally well tolerated in clinical trials. Common adverse events associated with … arthritis, leflunomide had a more rapid onset of action than methotrexate, sulfasalazine and placebo. In trials of 24 months …